Usage of the protein nicotinamide mononucleotide (NAD) adenylyl transferase (NMNAT) was shown to decrease behavioral and morphological deficiencies in a frontotemporal dementia Drosophila model by decreasing levels of tau oligomers (20). This evidence concerns the gene MAPT and frontotemporal dementia.